Migraine Drugs MarketPosted by ahila on April 26th, 2018 Global Migraine Drugs Market: By Drug Type, (Prophylactic, (Topiramate, Botulinum toxin), Abortive (Ergot Alkaloids, Triptans), By Route of Administration (Injectables, Oral), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Others), By Region – Market Estimation, Dynamics, Regional Share, Trends, Competitor Analysis 2012 to 2016 and Forecast 2017 to 2023 Market Outline: Global Migraine Drugs Market A migraine is a primary headache disorder characterized by moderate to a severe headache. Typically migraine headaches affect half of the head and generally pulsatile. A migraine may last in a range of two hours to 72 hours. Other symptoms may include nausea, vomiting, sensitivity to light, smell and sound. Migraines may be preceded by an aura of sensory disturbances followed by severing an often onside headache. There are two types of migraine drugs are present in the market. Prophylactic drugs are used for the prevention of precedence of a migraine. Whereas, no particular migraine therapy drugs are available. Market dynamics: Global Migraine Drugs Market Global migraine drugs market is mainly driven by the increase in the prevalence of migraine worldwide. In addition, rise in R&D activities by the market players to develop new drugs and expected commercialization of the pipeline drugs are projected to bolster the market during the forecast period. Furthermore, growing awareness in population regarding early diagnosis and treatment of migraine coupled with the rise in healthcare expenditure globally projected to boost the global migraine drugs market share. However, availability of the generic drugs, other treatment options such as neuromodulators and others expected to impede the market global migraine drugs market over the forecast period. A sample of this report is available upon request @ Market Scope: Global Migraine Drugs Market Global migraine drugs market is segmented based on drug type, route of administration, distribution channel, and region Based on drug type, market is segmented into
o Topiramate o Botulinum toxin
o Ergot Alkaloids o Triptans Based on route of administration, market is segmented into
Based on distribution channel, market is segmented into
Based on region, market is segmented into
Regional Analysis: Global Migraine Drugs Market Geographically migraine drugs market is divided into five key regions, i.e. Europe, North America, Latin America, Asia- Pacific, and The Middle East & Africa. North America migraine drugs market is anticipated to grow at significant rates owing to the factors such as rise in the occurrence of migraine, greater healthcare expenditure, and recent product launches. Asia Pacific migraine drugs market is expected to have notable market growth over the forecast period owing to the growth in a number of people suffering from the migraine and growing awareness related to early diagnosis and treatment. China and India expected to have lucrative growth opportunities owing to the lifestyle changes and high prevalence rates of migraine in the countries To view TOC of this report is available upon request @ Like it? Share it! More by this author |